Invistics

Tag Archives: Compliance

CDC Key Findings for Opioid Epidemic 1999-2015

03/03/2017

The Center for Disease Control, in it’s most recently updated Data Brief, listed the following as key findings: The age-adjusted rate of drug overdose deaths in the United States in 2015 (16.3 per 100,000) was more than 2.5 times… more →

Death, Taxes and DEA Inspections

12/01/2016

In his recent article, Hyman, Phelps & McNamara, P.C. Of Counsel, and former diversion investigator for the Drug Enforcement Administration, Larry K. Houck, explains the scope of DEA pre-registration and cyclic inspections as a step-by-step guide to actions and… more →

DEA Reduces Amount of Opioid Controlled Substances that may be Manufactured in 2017

10/05/2016

Yesterday, the United States Drug Enforcement Administration (DEA) dramatically decreased the amount of Schedule II opiate and opioid drugs that may be manufactured in 2017. Almost all of the reductions were 25% or more, with 33% reduction to hydrocodone. The… more →

Invistics Upcoming Conference Tour!

07/12/2016

In an effort to stay up-to-date on new strategies, ideas, and solutions in the industries that we serve, we will be attending the following upcoming conferences. Feel free to introduce yourself and say “hi” to our team, and we’ll be… more →

How Invistics Solutions can prevent Controlled Substance Diversion (4/4)

04/14/2016

Invistics Controlled Substance Blog Series: Invistics Joins the Fight Against Controlled Substance Diversion Silent Victims of Opioid Addiction: The Children When Opioid Addiction Hits Home: Atlanta In our Controlled Substance blog series so far, we’ve detailed the epidemic of opioid… more →